GVAG
BSX icon

Great Valley Advisor Group’s Boston Scientific BSX Stock Holding History

Great Valley Advisor Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
62,843
+10,352
+20% +$562K 0.04% 335
2026
Q1 		$3.29M Buy
52,491
+7,573
+17% +$606K 0.06% 278
2025
Q4 		$4.28M Buy
44,918
+5,688
+14% +$558K 0.08% 213
2025
Q3 		$3.83M Sell
39,230
-1,427
-4% -$148K 0.08% 217
2025
Q2 		$4.37M Buy
40,657
+1,830
+5% +$185K 0.1% 192
2025
Q1 		$3.92M Sell
38,827
-1,336
-3% -$135K 0.08% 207
2024
Q4 		$3.59M Sell
40,163
-292
-0.7% -$25.7K 0.08% 229
2024
Q3 		$3.39M Buy
40,455
+1,074
+3% +$84.7K 0.08% 234
2024
Q2 		$3.03M Buy
39,381
+3,577
+10% +$262K 0.08% 229
2024
Q1 		$2.45M Sell
35,804
-130
-0.4% -$8.36K 0.07% 241
2023
Q4 		$2.08M Buy
35,934
+9,859
+38% +$526K 0.07% 235
2023
Q3 		$1.38M Buy
26,075
+1,371
+6% +$71.9K 0.06% 271
2023
Q2 		$1.34M Buy
24,704
+3,157
+15% +$165K 0.06% 272
2023
Q1 		$1.08M Buy
21,547
+8,580
+66% +$404K 0.05% 293
2022
Q4 		$600K Sell
12,967
-149
-1% -$6.45K 0.03% 408
2022
Q3 		$508K Buy
13,116
+474
+4% +$19K 0.03% 416
2022
Q2 		$471K Buy
12,642
+4,457
+54% +$181K 0.03% 437
2022
Q1 		$362K Buy
8,185
+2,896
+55% +$126K 0.02% 459
2021
Q4 		$225K Buy
5,289
+358
+7% +$15K 0.01% 551
2021
Q3 		$214K Buy
+4,931
New +$218K 0.01% 539

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Great Valley Advisor Group's BSX Position: Q2 2026 in Review

Great Valley Advisor Group increased its Boston Scientific (BSX) stake by 20% in Q2 2026, buying an estimated $562K and bringing the position to 62,843 shares worth $2.68M. The position accounts for 0.04% of the portfolio, ranked #335.

Great Valley Advisor Group first reported a position in BSX in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.37M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Great Valley Advisor Group held 62,843 shares of Boston Scientific worth $2.68M as of Q2 2026.
  • Great Valley Advisor Group bought 10,352 Boston Scientific shares in Q2 2026, an estimated $562K.
  • Boston Scientific made up 0.04% of Great Valley Advisor Group's portfolio in Q2 2026, its #335 holding.
  • Great Valley Advisor Group first reported a position in Boston Scientific in Q3 2021 and has held it in 20 quarters since.
  • Great Valley Advisor Group's Boston Scientific position peaked at $4.37M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.